Figure 2.

BCR-free survival differentiated by the stratum (unfavorable resultant profile of ESR1 and MMP3) in combination with clinical parameters such as lymph node status, Gleason score, TNM, and stage (EAU risk groups for BCR), as well as preoperative PSA level groups. Detailed statistics of the above analyses are presented in Table 2.